2019, Number 2
<< Back Next >>
Rev Cubana Hematol Inmunol Hemoter 2019; 35 (2)
Blood donors characterization with positive irregular antibodies in Montería, Colombia 2012- 2015
Rolon TME, Hoyos GK, Correa OA, Villegas GR
Language: Spanish
References: 23
Page: 1-12
PDF size: 393.28 Kb.
ABSTRACT
Introduction: Irregular antibodies correspond to those other than natural anti-A or anti-B antibodies, which may appear in response to exposure to a foreign erythrocyte antigen (transfusion or transplantation) or due to maternal-fetal incompatibility.
Objective: To characterize the donors with positive irregular antibody screening of a blood bank in Monteria, Colombia during the period 2012-2015.
Methods: Cross-sectional and retrospective study, with secondary information source, based on the results of the antibody screening in donors of a blood bank in Monteria, Colombia from 2012 to 2015. The population consisted of all voluntary donors registered in the study time (35 248 donors), who were screened for antibodies. As a sample, all cases that had positive results (71 donors) were selected. The data was organized in tables and analyzed in the software SPSS 21.0, Microsoft Excel and in Epidat version 3.1.
Results: 0.2% of the population presented a positive antibody screen with a confidence interval between 0.15 and 0.25%. Irregular antibodies were more frequent in men and in O Rh positive donors. Thirteen types of irregular antibodies were found, with predominance of anti-M, anti-Lea, anti-D and anti-E and respective percentages of 27.78%, 20.83%, 9.72% and 8.33%. 50% of the donors were 30.5 years old or less, 49.3% had previously donated and 9.9% received at least one transfusion at some point in their lives.
Conclusion: The frequency of donors with irregular positive antibody screening was low, the male sex had a higher percentage, it was detected mainly in blood group O and within the irregular antibodies, anti-M showed a higher frequency.
REFERENCES
Miralles Carty M, Fernández-Delgado N, Bencomo-Hernández A, Martínez-Martínez A, Levón-Herrera R. Detección de anticuerpos eritrocitarios con las técnicas de polietilenglicol y polibreno en pacientes politransfundidos. Rev Cubana Hematol Inmunol Hemoter.2016;32(1):119-24.
Körmöczi GF, Mayr WR. Responder individuality in red blood cell alloimmunization.Transfus Med Hemother. 2014;41(6):446-51.
Ministerio de Salud y Protección Social. Resolución 0901 de 1996: Por la cual se adopta el Manual de Normas Técnicas, Administrativas y de Procedimientos para bancos de sangre. Bogotá, D.C: 20 de marzo de 1996. [Citado 28/09/2017] Disponible en: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/DE/DIJ/RESOLUCION_0901_de_1996.pdf
Garg N, Sharma T, Singh B. Prevalence of irregular red blood cell antibodies among healthy blood donors in Delhi population. Transfus Apher Sci. 2014;50(3):415-7.
Karim F, Moiz B, Kamran N. Risk of maternal alloimmunization in Southern Pakistan -a study in a cohort of 1000 pregnant women. Transfus Apher Sci. 2015; 52(1):99-102.
BrandA. Immunological complications of blood transfusions. Presse Med. 2016; 45:313–24.
Davari K, Soltanpour MS. Study of alloimmunization and autoimmunization in Iranian β-thalassemia major patients. Asian J Transfus Sci. 2016;10(1):88–92.
Karafin MS, Denomme GA, Bryant BJ. The future of red blood cell alloimmunization risk reduction.Transfusion.2015;55(1):220–1.
Instituto Nacional de Salud. Informe Nacional de indicadores red nacional Bancos de sangre y servicios de transfusión. Mayo 2016. [Citado 28/06/2017] Disponible en: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/IA/INS/ins-informe-anual-red-sangre-2015.pdf
Poole J, Daniels G. Blood group antibodies and their significance in transfusion medicine. Transfus Med Rev. 2007;21(1):58-71.
11.Kaur D, Bains L, Kandwal M, Parmar I. Erythrocyte Alloimmunization and Autoimmunization among Blood Donors and Recipients visiting a Tertiary Care Hospital. J Clin Diagn Res. 2017;11(3):EC12-EC15.
12.Cossio A, India E, Solis A, Castellón N, Dávalos M, Jarro R. Tipificación del grupo sanguíneo ABO y el factor Rh en la población de Totora-Cochabamba gestión 2012. Rev Cient Cienc Med. 2013;16(1):25-7.
13.Bermúdez HC, Moreno JC, Forero E. Caracterización de Donantes voluntarios de sangre por grupo sanguíneo ABO y Rh que asistieron a un Banco de sangre de la ciudad de Tunja- Colombia. Arch Med.2012;12(2):185-9.
Carmona-Fonseca J. Frecuencia de los grupos sanguíneos ABO y Rh en la población laboral del valle de Aburrá y del cercano oriente de Antioquia (Colombia). Acta Médica Colombiana 2006;31(1):20-30.
15.Geifman-Holtzman O, Wojtowycz M, Kosmas E, Artal R. Female alloimmunization with antibodies known to cause hemolytic disease. Obstet Gynecol.1997; 89:272-5.
16.M’baya B, Mfune T, Mogombo E, Mphalalo A, Ndhlovu D. The prevalence of red cell antigens and antibodies in Malawi. Transfus Med. 2010;20(3):196-9.
Reid M, Lomas C. MNS Blood Group System. The Blood Group Antigen Facts Book. 3rd ed. Amsterdam: Elsevier; 2012: 53–134.
Shin KH, Lee HJ, Kim HH, Hong YJ, Park KU, Kim MJ et al. Frequency of Red Blood Cell Antigens According to Parent Ethnicity in Korea Using Molecular Typing. Ann Lab Med.2 018; 38:599-603.
Valle Neto OGD, Alves VM, Pereira GA, Moraes-Souza H, Martins PRJ. Clinical and epidemiological profile of alloimmunized and autoimmunized multi-transfused patients against red blood cell antigens in a blood center of Minas Gerais. Hematol Transfus Cell Ther. 2018;40(2):107-111.
Villa M, Pérez R, Cardona J. Detección de anticuerpos irregulares en pacientes transfundidos en una clínica de Medellín, Colombia entre 2007-2010. Hechos Microbiol. 2012;3(2):17-24.
Ghesquière L, Garabedian C, Coulon C, Verpillat P, Rakza T, Wibaut B et al. Management of red blood cell alloimmunization in pregnancy. J Gynecol Obstet Hum Reprod. 2018;47(5):197-204.
Ferrer R, Laurenzo C, Avila E. Enfermedad Hemolítica del recién nacido por isoinmunización a grupos sanguíneos menores. Un caso Poco frecuente. Multimed. 2016; 20(3):624–30.
Kumar B, Ravimohan V, Alfirevic A. Red-cell alloimmunization. Obstet Gynaecol Reprod Med. 2010;20(2):47-56.